Cardima
Fremont
About Cardima
Cardima, designs, develops, manufactures and markets minimally invasive, single-use, microcatheter-based systems for the mapping and ablation of the two most common forms of cardiac arrhythmias: atrial fibrillation and ventricular tachycardia. Arrhythmias are abnormal electrical heart rhythms that adversely affect the mechanical activities of the heart and can potentially be fatal. The Company is developing microcatheter systems designed to provide enhanced access to arrhythmia causing tissue, to diagnose the arrhythmia by locating its origin ("mapping") and to restore normal heart rhythms by isolating and destroying the arrhythmia causing sites ("ablation") using radiofrequency ("RF") energy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Funding stage: M&A
- Last round: Debt Financing (May 2005)
- Ticker: nasdaq:CRDM
- Website: cardima.com
Industries & Categories
Health Care, Manufacturing
Canonical: https://fsome.com/organization/cardima-2122628 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.